MeSH tree: C06.552.241
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in Nutrition & Diabetes.
Feb 27, 2026
0
0
Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that may lead to better disease ...
Feb 26, 2026
0
0
Researchers at University of California San Diego School of Medicine have developed a new, easy-to-use blood test score that can help identify when fatty liver disease is being driven by excessive alcohol use, an important ...
Feb 25, 2026
0
1
According to recent reports from the Korean government, the incidence of alcoholic liver disease—previously the leading indication for liver transplantation—has been decreasing. This trend initially raised expectations ...
Feb 16, 2026
0
0
A new orally taken, gut-based compound developed by scientists from Nanyang Technological University, Singapore (NTU Singapore), reduces the amount of dietary fat absorbed in the intestines. This differs from most existing ...
Feb 11, 2026
0
0
Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose as a necessary and metabolically active organ, carrying out many vital functions within the body. In the case of obesity, ...
Feb 9, 2026
0
0
Two UT Southwestern Medical Center researchers have identified a protein that plays a key role in controlling the liver's release of cholesterol-carrying lipoproteins into the bloodstream, a discovery that could lead to new ...
Feb 3, 2026
0
37
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead to the development of ...
Feb 3, 2026
0
28
People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science Advances has found that low-protein ...
Jan 29, 2026
0
41
A multicenter research effort in China conducted clinical trial testing of oral berberine for six months in diabetes-free adults with obesity and metabolic dysfunction-associated steatotic liver disease. Visceral adipose ...
